NASH Core Curriculum: Emerging Management

Hear expert perspectives on histologic and metabolic endpoints in NASH studies and how they may inform potential targets for oral, injectable, and combination NASH treatments.
Stephen Harrison, MD, FACP, FAASLD, COL (ret.) USA, MC
Format: Microsoft PowerPoint (.ppt)
File Size: 2.72 MB
Released: July 20, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Supported by educational grants from
Gilead Sciences
Novo Nordisk Inc.

Related Content

Learn from an expert about emerging strategies for combination treatment for NASH with GLP-1 receptor agonists plus SGLT2 inhibitors, from Clinical Care Options (CCO)

Manal F. Abdelmalek, MD, MPH Released: February 2, 2023

A quick reference guide to identify obesity specialists in or near Kansas City, from Clinical Care Options (CCO)

Released: January 23, 2023

A quick reference guide to identify obesity specialists in Indiana, from Clinical Care Options (CCO)

Released: January 20, 2023

Expert answers to learner questions from a live symposium with simulcast about strategies for a proactive approach to obesity management, from Clinical Care Options (CCO)

Caroline Apovian, MD Ken Fujioka, MD Released: January 13, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings